CD44 and breast carcinoma: Breast cancer cells that have low expression of CD24 in combination with high expression of CD44 (CD24−/CD44+) and high aldehyde dehydrogenase (ALDH) activity are known as breast cancer stem cells (BCSCs) (Al-Hajj et al., 2003; Douville et al., 2009).